The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide

被引:156
作者
Buter, H
Hemmelder, MH
Navis, G
de Jong, PE
de Zeeuw, D
机构
[1] State Univ Hosp, Dept Med, Div Nephrol, GIDS, NL-9713 GZ Groningen, Netherlands
[2] State Univ Hosp, Div Clin Pharmacol, Groningen, Netherlands
关键词
ACE inhibition; hydrochlorothiazide; nondiabetic renal disease; proteinuria; sodium restriction;
D O I
10.1093/ndt/13.7.1682
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Dietary sodium restriction enhances the antiproteinuric and blood pressure lowering effect of ACE inhibition. In clinical practice, however, long-term compliance to a low-sodium diet may be difficult to obtain. We therefore investigated whether the blunting of the antiproteinuric and blood pressure lowering efficacy of ACE inhibition by high sodium intake can be restored by the addition of a diuretic. Patients and methods. Seven proteinuric patients with non-diabetic renal disease on chronic ACE inhibition were studied during three consecutive 4-week periods: low sodium (50 mmol/day), high sodium (200 mmol/day) and high sodium plus hydrochlorothiazide (50 mg o.i.d.). Results. During low sodium intake proteinuria was 3.1 (0.7-5.2) g/day, during high sodium intake proteinuria increased to 4.5 (1.6-9.2)g/day (P<0.05). Interestingly, addition of hydrochlorothiazide again reduced proteinuria to 2.8 (0.6-5.8)g/day (P<0.05). Mean arterial blood pressure was 89 (84-96), 98 (91-104) and 89 (83-94)mmHg (P<0.05) during the three periods, respectively. Conclusion. Addition of hydrochlorothiazide can overcome the blunting of the therapeutic efficacy of ACE inhibition on proteinuria and blood pressure by a high sodium intake.
引用
收藏
页码:1682 / 1685
页数:4
相关论文
共 14 条
[1]   LONG-TERM BENEFITS OF THE ANTIPROTEINURIC EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN NONDIABETIC RENAL-DISEASE [J].
GANSEVOORT, RT ;
DEZEEUW, D ;
DEJONG, PE .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 22 (01) :202-206
[2]  
GANSEVOORT RT, 1995, NEPHROL DIAL TRANSPL, V10, P1963
[3]   EFFICACY AND VARIABILITY OF THE ANTIPROTEINURIC EFFECT OF ACE INHIBITION BY LISINOPRIL [J].
HEEG, JE ;
DEJONG, PE ;
VANDERHEM, GK ;
DEZEEUW, D .
KIDNEY INTERNATIONAL, 1989, 36 (02) :272-279
[4]   REDUCTION OF PROTEINURIA BY ANGIOTENSIN CONVERTING ENZYME-INHIBITION [J].
HEEG, JE ;
DEJONG, PE ;
VANDERHEM, GK ;
DEZEEUW, D .
KIDNEY INTERNATIONAL, 1987, 32 (01) :78-83
[5]   ANGIOTENSIN CONVERTING ENZYME-INHIBITION AND CALCIUM-CHANNEL BLOCKADE IN INCIPIENT DIABETIC NEPHROPATHY [J].
JERUMS, G ;
ALLEN, TJ ;
TSALAMANDRIS, C ;
COOPER, ME .
KIDNEY INTERNATIONAL, 1992, 41 (04) :904-911
[6]   THE EFFECTS OF DIETARY-PROTEIN RESTRICTION AND BLOOD-PRESSURE CONTROL ON THE PROGRESSION OF CHRONIC RENAL-DISEASE [J].
KLAHR, S ;
LEVEY, AS ;
BECK, GJ ;
CAGGIULA, AW ;
HUNSICKER, L ;
KUSEK, JW ;
STRIKER, G ;
BUCKALEW, V ;
BURKART, J ;
FURBERG, C ;
FELTS, J ;
MOORE, M ;
ROCCO, H ;
DOLECEK, T ;
WARREN, S ;
BEARDEN, B ;
STARKEY, C ;
HARVEY, J ;
POOLE, D ;
DAHLQUIST, S ;
DOROSHENKO, L ;
BRADHAM, K ;
WEST, D ;
AGOSTINO, J ;
COLE, L ;
BAKER, B ;
HAIRSTON, K ;
BURGOYNE, S ;
LAZARUS, J ;
STEINMAN, T ;
SEIFTER, J ;
DESMOND, M ;
FIORENZO, M ;
CHIAVACCI, A ;
METALIDES, T ;
KORZECRAMIREZ, D ;
GOULD, S ;
PICKETT, V ;
PORUSH, J ;
FAUBERT, P ;
SPITALEWITZ, S ;
FAUBERT, J ;
ZIMMER, G ;
SAUM, D ;
BLOCK, M ;
WOEL, J ;
ROSE, M ;
DENNIS, V ;
SCHWAB, S ;
MINDA, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (13) :877-884
[7]   Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency [J].
Maschio, G ;
Alberti, D ;
Janin, G ;
Locatelli, F ;
Mann, JFE ;
Motolese, M ;
Ponticelli, C ;
Ritz, E ;
Zucchelli, P ;
Marai, P ;
Marcelli, D ;
Tentori, F ;
Andriani, M ;
Drago, G ;
Meneghel, G ;
Oldrizzi, L ;
Rugiu, C ;
Salvadeo, A ;
Villa, G ;
Picardi, L ;
Borghi, M ;
Moriggi, M ;
Vendramin, G ;
Fusaroli, M ;
Esposti, ED ;
Fabbri, A ;
Koch, KM ;
Frey, U ;
Schaeffer, J ;
Mann, J ;
Schweitzer, C ;
Zuccala, A ;
Gaggi, R ;
Stahl, R ;
Blaser, C ;
Rivolta, E ;
Buccianti, G ;
Gastaldi, L ;
Baratelli, M ;
Ducret, F ;
Pointet, P ;
Sterzel, R ;
Oberdorf, E ;
Pedrini, L ;
Faranna, P ;
Cairo, G ;
Ferrari, L ;
Albertazzi, A ;
Cappelli, P ;
Cantu, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (15) :939-945
[8]  
Navis G, 1996, J HUM HYPERTENS, V10, P669
[9]   THE INCREASED RISK OF CORONARY HEART-DISEASE ASSOCIATED WITH NEPHROTIC SYNDROME [J].
ORDONEZ, JD ;
HIATT, RA ;
KILLEBREW, EJ ;
FIREMAN, BH .
KIDNEY INTERNATIONAL, 1993, 44 (03) :638-642
[10]   IS GLOMERULOSCLEROSIS A CONSEQUENCE OF ALTERED GLOMERULAR-PERMEABILITY TO MACROMOLECULES [J].
REMUZZI, G ;
BERTANI, T .
KIDNEY INTERNATIONAL, 1990, 38 (03) :384-394